These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 7518526)

  • 1. Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection.
    Kato N; Ootsuyama Y; Sekiya H; Ohkoshi S; Nakazawa T; Hijikata M; Shimotohno K
    J Virol; 1994 Aug; 68(8):4776-84. PubMed ID: 7518526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus.
    Kato N; Sekiya H; Ootsuyama Y; Nakazawa T; Hijikata M; Ohkoshi S; Shimotohno K
    J Virol; 1993 Jul; 67(7):3923-30. PubMed ID: 7685404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic alterations of the putative envelope proteins encoding region of the hepatitis C virus in the progression to relapsed phase from acute hepatitis: humoral immune response to hypervariable region 1.
    Sekiya H; Kato N; Ootsuyama Y; Nakazawa T; Yamauchi K; Shimotohno K
    Int J Cancer; 1994 Jun; 57(5):664-70. PubMed ID: 7515022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus isolate-specific antibodies against hypervariable region 1 of the hepatitis C virus second envelope protein, gp70.
    Kato N; Nakazawa T; Ootsuyama Y; Sugiyama K; Ohkoshi S; Shimotohno K
    Jpn J Cancer Res; 1994 Oct; 85(10):987-91. PubMed ID: 7525524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (gp70) hypervariable region 1 in viremic hepatitis C virus-infected patients.
    Scarselli E; Cerino A; Esposito G; Silini E; Mondelli MU; Traboni C
    J Virol; 1995 Jul; 69(7):4407-12. PubMed ID: 7539508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sequence diversity and variability in the putative envelope proteins including hypervariable regions of hepatitis C virus].
    Nakazawa T; Hijikata M; Kato N; Shimotohno K
    Nihon Rinsho; 1993 Feb; 51(2):318-22. PubMed ID: 8385235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic alteration of the hepatitis C virus hypervariable region obtained from an asymptomatic carrier.
    Nakazawa T; Kato N; Ootsuyama Y; Sekiya H; Fujioka T; Shibuya A; Shimotohno K
    Int J Cancer; 1994 Jan; 56(2):204-7. PubMed ID: 8314302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment.
    Zibert A; Schreier E; Roggendorf M
    Virology; 1995 Apr; 208(2):653-61. PubMed ID: 7538251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of hypervariable regions in the putative envelope protein of hepatitis C virus.
    Kato N; Ootsuyama Y; Ohkoshi S; Nakazawa T; Sekiya H; Hijikata M; Shimotohno K
    Biochem Biophys Res Commun; 1992 Nov; 189(1):119-27. PubMed ID: 1333186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants.
    Puntoriero G; Meola A; Lahm A; Zucchelli S; Ercole BB; Tafi R; Pezzanera M; Mondelli MU; Cortese R; Tramontano A; Galfre' G; Nicosia A
    EMBO J; 1998 Jul; 17(13):3521-33. PubMed ID: 9649423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A correlation between the heterogeneity of hypervariable region 1 of E2 glycoprotein of Hepatitis C virus (HCV) and HCV antibody profile: a case study.
    Kmieciak D; Biernacka-Lukanty J; Migdalski P; Turek-Plewa J; Wierzbicki A; Juszczyk J; Trzeciak WH
    Acta Virol; 2005; 49(2):97-103. PubMed ID: 16047736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network Analysis of the Chronic Hepatitis C Virome Defines Hypervariable Region 1 Evolutionary Phenotypes in the Context of Humoral Immune Responses.
    Palmer BA; Schmidt-Martin D; Dimitrova Z; Skums P; Crosbie O; Kenny-Walsh E; Fanning LJ
    J Virol; 2015 Dec; 90(7):3318-29. PubMed ID: 26719263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequences in the hypervariable region 1 of hepatitis C virus show only minimal variability in the presence of antibodies against hypervariable region 1 during acute infection in chimpanzees.
    Zhou YH; Sugitani M; Esumi M
    Arch Virol; 2002 Oct; 147(10):1955-62. PubMed ID: 12376756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine antibodies against E2 and hypervariable region 1 cross-reactively capture hepatitis C virus.
    Esumi M; Ahmed M; Zhou YH; Takahashi H; Shikata T
    Virology; 1998 Nov; 251(1):158-64. PubMed ID: 9813211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marked sequence diversity in the putative envelope proteins of hepatitis C viruses.
    Kato N; Ootsuyama Y; Tanaka T; Nakagawa M; Nakazawa T; Muraiso K; Ohkoshi S; Hijikata M; Shimotohno K
    Virus Res; 1992 Feb; 22(2):107-23. PubMed ID: 1314471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C.
    Pawlotsky JM; Pellerin M; Bouvier M; Roudot-Thoraval F; Germanidis G; Bastie A; Darthuy F; Rémiré J; Soussy CJ; Dhumeaux D
    J Med Virol; 1998 Apr; 54(4):256-64. PubMed ID: 9557291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies directed to envelope proteins of hepatitis C virus outside of hypervariable region 1.
    Lechner S; Rispeter K; Meisel H; Kraas W; Jung G; Roggendorf M; Zibert A
    Virology; 1998 Apr; 243(2):313-21. PubMed ID: 9568031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variations in the hypervariable region 1 of the envelope region E2 of hepatitis C virus RNA appear associated with virus persistence independently of liver disease.
    Brunetto MR; Suzuki T; Aizaky H; Flichman D; Colombatto P; Abate ML; Oliveri F; Matsuura Y; Bonino F; Miyamura T
    Ital J Gastroenterol; 1996 Dec; 28(9):499-504. PubMed ID: 9131394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a plant-derived subunit vaccine candidate against hepatitis C virus.
    Nemchinov LG; Liang TJ; Rifaat MM; Mazyad HM; Hadidi A; Keith JM
    Arch Virol; 2000; 145(12):2557-73. PubMed ID: 11205105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine.
    Law JLM; Logan M; Wong J; Kundu J; Hockman D; Landi A; Chen C; Crawford K; Wininger M; Johnson J; Mesa Prince C; Dudek E; Mehta N; Tyrrell DL; Houghton M
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29540595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.